EssilorLuxottica Société anonyme (EL.PA)
The price, the headline numbers and the latest news, in one place.
EssilorLuxottica Société anonyme (EL.PA) Stock Price, Analysis & Data
No data available
| Bid | 0 |
| Market Cap | 70.2B |
| Revenue (ttm) | 29.3B |
| Net Income (ttm) | 2.49B |
| 0.55 | |
| 5.35 | |
| 28.59 | |
| 18.85 | |
| P/B (ttm) | 1.79 |
| P/S (ttm) | 2.40 |
| Earnings Date | Feb 11, 2027 |
| Ask | 0 |
| Volume | 147,515 |
| Avg. Volume (20D) | 689,851 |
| Open | 159.20 |
| Previous Close | 159.15 |
| Day's Range | 159.20 - 161.50 |
| 52-Week Range | 159.15 - 323.80 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $4.00 (2.52%) |
| Ex-Dividend Date | May 5, 2026 |
About EL.PA
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Op...
Financial Performance
In 2025, EssilorLuxottica Société anonyme's revenue was 28.49B, an increase of 7.48% compared to the previous year's 26.51B. Earnings were 2.32B, a decrease of -1.87%.
Financial numbers in EUR Financial StatementsEarnings Surprise
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Analysts project revenue of ... Upgrade
1 week ago · The Wall Street Journal
Health Care Roundup: Market TalkFind insight on Novo Nordisk, EssilorLuxottica and more in the latest Market Talks covering the health care sector.
